BridgeBio Pharma, Inc. Uncategorized Contracts & Agreements
19 Contracts & Agreements
- Second Amendment, effective as of August 15, 2023, to the Exclusive (Equity) Agreement, by and between Eidos Therapeutics, Inc. and the Board of Trustees of the Leland Stanford... (Filed With SEC on November 2, 2023)
- Description of Securities (Filed With SEC on February 25, 2022)
- Description of Securities (Filed With SEC on February 25, 2021)
- Form of Confirmation for Capped Call Transactions (Filed With SEC on January 29, 2021)
- Form of Confirmation for Capped Call Transactions (Filed With SEC on March 10, 2020)
- Offer Letter, between BridgeBio Pharma, Inc. and James C. Momtazee, dated February 23, 2020 (Filed With SEC on March 3, 2020)
- Description of Securities (Filed With SEC on March 3, 2020)
- Offer Letter, between and BridgeBio Services, Inc. and Yi Ching Yau, dated September 9, 2019 (Filed With SEC on November 8, 2019)
- Offer Letter, between BridgeBio Pharma, Inc. and Brian Stolz, dated September 19, 2019 (Filed With SEC on November 8, 2019)
- Form of Tax Sharing Agreement, between the Registrant and each of its subsidiaries (Filed With SEC on June 24, 2019)
- Offer Letter, between Eidos Therapeutics, Inc. and Cameron Turtle, dated June 13, 2018 (Filed With SEC on June 11, 2019)
- Offer Letter, between BridgeBio Services, Inc. and Cameron Turtle, dated December 13, 2016, as amended on May 5, 2017 (Filed With SEC on June 11, 2019)
- Offer Letter, between BridgeBio Services, Inc. and Michael Henderson, dated March 22, 2016, as amended on May 5, 2017 (Filed With SEC on June 11, 2019)
- Offer Letter, between BridgeBio Services, Inc. and Richard Scheller, dated April 5, 2019 (Filed With SEC on June 11, 2019)
- Offer Letter, between BridgeBio Services, Inc. and Charles Homcy, dated February 20, 2019 (Filed With SEC on June 11, 2019)
- Offer Letter, between Eidos Therapeutics, Inc. and Uma Sinha, dated June 1, 2016, as amended on May 24, 2018 (Filed With SEC on June 11, 2019)
- Offer Letter, between BridgeBio Services, Inc. and Brian Stephenson, dated October 28, 2018 (Filed With SEC on June 11, 2019)
- Offer Letter, between BridgeBio Services, Inc. and Neil Kumar, dated December 14, 2017 (Filed With SEC on June 11, 2019)
- Exclusive (Equity) Agreement, by and between Eidos Therapeutics, Inc. and the Board of Trustees of the Leland Stanford Junior University, effective as of April 10, 2016, as... (Filed With SEC on May 24, 2019)
